iSpecimen Inc. (ISPC) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
ISPC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ISPC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 1.2% | -465.4% | -543.7% |
| 2024 | 42.9% | -137.0% | -134.5% |
| 2023 | 51.4% | -112.5% | -111.8% |
| 2022 | 54.3% | -97.9% | -98.5% |
| 2021 | 52.9% | -53.2% | -80.5% |
Download Data
Export ISPC earnings history in CSV or JSON format
Free sign-in required to download data
iSpecimen Inc. (ISPC) Earnings Overview
As of May 8, 2026, iSpecimen Inc. (ISPC) reported trailing twelve-month net income of -$10M, reflecting +87.0% year-over-year growth. The company earned $-91.15 per diluted share over the past four quarters, with a net profit margin of -543.7%.
Looking at the long-term picture, ISPC's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2020.
iSpecimen Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BRLT (-$12M net income, -0.8% margin), MEDP ($460M net income, 17.8% margin), BLFS (-$10M net income, -12.6% margin), ISPC has room to improve margins relative to the peer group. Compare ISPC vs BRLT →
ISPC Earnings vs Peers
Earnings metrics vs comparable public companies
ISPC Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$10M | +16.1% | -$9M | $-91.20 | -543.7% | -465.4% |
| 2024 | -$12M | -12.6% | -$13M | $-703.20 | -134.5% | -137.0% |
| 2023 | -$11M | -8.3% | -$11M | $-982.00 | -111.8% | -112.5% |
| 2022 | -$10M | -14.3% | -$10M | $-817.60 | -98.5% | -97.9% |
| 2021 | -$9M | -92.6% | -$6M | $-980.40 | -80.5% | -53.2% |
| 2020 | -$5M | +1.6% | -$2M | $-5775.20 | -56.8% | -29.4% |
| 2019 | -$5M | +11.6% | -$4M | $-4039.60 | -110.0% | -90.3% |
| 2018 | -$5M | - | -$3M | $-4564.40 | -121.7% | -76.4% |
See ISPC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ISPC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ISPC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonISPC — Frequently Asked Questions
Quick answers to the most common questions about buying ISPC stock.
Is ISPC growing earnings?
ISPC EPS is $-91.15, with earnings growth accelerating to +87.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-10M.
What are ISPC's profit margins?
iSpecimen Inc. net margin is -543.7%, with operating margin at -465.4%. Below-average margins reflect competitive or cost pressures.
How consistent are ISPC's earnings?
ISPC earnings data spans 2018-2025. The accelerating earnings trend is +87.0% YoY. Historical data enables comparison across business cycles.